Sarah Lewington, Ben Lacey, Robert Clarke, Yu Guo, Xiang Ling Kong, Ling Yang, Yiping Chen, Zheng Bian, Junshi Chen, Jinhuai Meng, Youping Xiong, Tianyou He, Zengchang Pang, Shuo Zhang, Rory Collins, Richard Peto, Liming Li, Zhengming Chen
IMPORTANCE: Hypertension is a leading cause of premature death in China, but limited evidence is available on the prevalence and management of hypertension and its effect on mortality from cardiovascular disease (CVD). OBJECTIVES: To examine the prevalence, diagnosis, treatment, and control of hypertension and to assess the CVD mortality attributable to hypertension in China. DESIGN, SETTING AND PARTICIPANTS: This prospective cohort study (China Kadoorie Biobank Study) recruited 500 223 adults, aged 35 to 74 years, from the general population in China...
April 2016: JAMA Internal Medicine